Ngā hua rapu kaituhi

1

Gene Silencing by Small Regulatory RNAs in Mammalian Cells mā Michaela Scherr, Matthias Eder

I whakaputaina 2007

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
2

[68Ga]Ga-PSMA-11: The First FDA-Approved 68Ga-Radiopharmaceutical for PET Imaging of Prostate Cancer mā Ute Hennrich, Matthias Eder

I whakaputaina 2021

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
3

[177Lu]Lu-PSMA-617 (PluvictoTM): The First FDA-Approved Radiotherapeutical for Treatment of Prostate Cancer mā Ute Hennrich, Matthias Eder

I whakaputaina 2022

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
4

Functional optical probing of the hippocampal trisynaptic circuit in vitro: network dynamics, filter properties, and polysynaptic induction of CA1 LTP mā Jens Stepan, Julien Dine, Matthias Eder

I whakaputaina 2015

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
5

Dual-Labeled Small Peptides in Cancer Imaging and Fluorescence-Guided Surgery: Progress and Future Perspectives mā Patrick G. Minges, Matthias Eder, Ann-Christin Eder

I whakaputaina 2025

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
6

PSMA as a target for radiolabelled small molecules mā Matthias Eder, Michael Eisenhut, John W. Babich, Uwe Haberkorn

I whakaputaina 2013

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Editorial

Tiaki ki tētahi rārangi

I tiakina i:
7

[177Lu]Lu-PSMA-617 Salivary Gland Uptake Characterized by Quantitative In Vitro Autoradiography mā Roswitha Tönnesmann, Philipp T. Meyer, Matthias Eder, Ann-Christin Baranski

I whakaputaina 2019

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
8

Novel Bispecific PSMA/GRPr Targeting Radioligands with Optimized Pharmacokinetics for Improved PET Imaging of Prostate Cancer mā Christos Liolios, Martin Schäfer, Uwe Haberkorn, Matthias Eder, Klaus Kopka

I whakaputaina 2016

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
9

Dietary Polyphenols in the Prevention of Stroke mā Anna Tresserra‐Rimbau, Sara Arranz, Matthias Eder, Anna Vallverdú‐Queralt

I whakaputaina 2017

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
10

Specific inhibition of bcr-abl gene expression by small interfering RNA mā Michaela Scherr, Karin Battmer, Thomas Winkler, Olaf Heidenreich, Arnold Ganser, Matthias Eder

I whakaputaina 2003

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
11

Preclinical evaluation of a bispecific low‐molecular heterodimer targeting both PSMA and GRPR for improved PET imaging and therapy of prostate cancer mā Matthias Eder, Martin Schäfer, Ulrike Bauder‐Wüst, Uwe Haberkorn, Michael Eisenhut, Klaus Kopka

I whakaputaina 2014

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
12

Activation of the Cannabinoid Receptor Type 1 Decreases Glutamatergic and GABAergic Synaptic Transmission in the Lateral Amygdala of the Mouse mā Shahnaz Christina Azad, Matthias Eder, Giovanni Marsicano, Beat Lutz, W. Zieglgänsberger, Gerhard Rammes

I whakaputaina 2003

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
13

PSMA-Targeting Radiopharmaceuticals for Prostate Cancer Therapy: Recent Developments and Future Perspectives mā Mohamed El Fakiri, Nicolas M. Geis, Nawal Ayada, Matthias Eder, Ann-Christin Eder

I whakaputaina 2021

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
14

Enhanced sensitivity to inhibition of SHP2, STAT5, and Gab2 expression in chronic myeloid leukemia (CML) mā Michaela Scherr, Anuhar Chaturvedi, Karin Battmer, Iris Dallmann, Beate Schultheis, Arnold Ganser, Matthias Eder

I whakaputaina 2005

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
15

Shc phosphorylation in myeloid cells is regulated by granulocyte macrophage colony-stimulating factor, interleukin-3, and steel factor and is constitutively increased by p210BCR/AB... mā Tetsuya Matsuguchi, Ravi Salgia, Michael Hallek, Matthias Eder, Brian J. Druker, T J Ernst, James D. Griffin

I whakaputaina 1994

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
16

Incidence, risk factors and healthcare costs of central line-associated nosocomial bloodstream infections in hematologic and oncologic patients mā Claas Baier, Lena Linke, Matthias Eder, Frank Schwab, Iris F. Chaberny, Ralf‐Peter Vonberg, Ella Ebadi

I whakaputaina 2020

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
17

Towards Improving the Efficacy of PSMA-Targeting Radionuclide Therapy for Late-Stage Prostate Cancer—Combination Strategies mā D. Arbuznikova, Matthias Eder, Anca‐Ligia Grosu, Philipp T. Meyer, Christian Gratzke, Constantinos Zamboglou, Ann-Christin Eder

I whakaputaina 2023

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
18

A dimerized urea-based inhibitor of the prostate-specific membrane antigen for 68Ga-PET imaging of prostate cancer mā Martin Schäfer, Ulrike Bauder‐Wüst, Karin Leotta, Frederic Zoller, Walter Mier, Uwe Haberkorn, Michael Eisenhut, Matthias Eder

I whakaputaina 2012

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
19

Lentivirus-mediated antagomir expression for specific inhibition of miRNA function mā Michaela Scherr, Letizia Venturini, Karin Battmer, Michael Schaller-Schoenitz, Daniel Schaefer, Iris Dallmann, Arnold Ganser, Matthias Eder

I whakaputaina 2007

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
20

68Ga-PSMA-11 Dynamic PET/CT Imaging in Primary Prostate Cancer mā Christos Sachpekidis, Klaus Kopka, Matthias Eder, Boris Hadaschik, Martin T. Freitag, Leyun Pan, Uwe Haberkorn, Antonia Dimitrakopoulou‐Strauss

I whakaputaina 2016

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:

Ngā hua rapu - Matthias Eder

Gene Silencing by Small Regulatory RNAs in Mammalian Cells mā Michaela Scherr, Matthias Eder

[68Ga]Ga-PSMA-11: The First FDA-Approved 68Ga-Radiopharmaceutical for PET Imaging of Prostate Cancer mā Ute Hennrich, Matthias Eder

[177Lu]Lu-PSMA-617 (PluvictoTM): The First FDA-Approved Radiotherapeutical for Treatment of Prostate Cancer mā Ute Hennrich, Matthias Eder

Functional optical probing of the hippocampal trisynaptic circuit in vitro: network dynamics, filter properties, and polysynaptic induction of CA1 LTP mā Jens Stepan, Julien Dine, Matthias Eder

Dual-Labeled Small Peptides in Cancer Imaging and Fluorescence-Guided Surgery: Progress and Future Perspectives mā Patrick G. Minges, Matthias Eder, Ann-Christin Eder

PSMA as a target for radiolabelled small molecules mā Matthias Eder, Michael Eisenhut, John W. Babich, Uwe Haberkorn

[177Lu]Lu-PSMA-617 Salivary Gland Uptake Characterized by Quantitative In Vitro Autoradiography mā Roswitha Tönnesmann, Philipp T. Meyer, Matthias Eder, Ann-Christin Baranski

Novel Bispecific PSMA/GRPr Targeting Radioligands with Optimized Pharmacokinetics for Improved PET Imaging of Prostate Cancer mā Christos Liolios, Martin Schäfer, Uwe Haberkorn, Matthias Eder, Klaus Kopka

Dietary Polyphenols in the Prevention of Stroke mā Anna Tresserra‐Rimbau, Sara Arranz, Matthias Eder, Anna Vallverdú‐Queralt

Specific inhibition of bcr-abl gene expression by small interfering RNA mā Michaela Scherr, Karin Battmer, Thomas Winkler, Olaf Heidenreich, Arnold Ganser, Matthias Eder

Preclinical evaluation of a bispecific low‐molecular heterodimer targeting both PSMA and GRPR for improved PET imaging and therapy of prostate cancer mā Matthias Eder, Martin Schäfer, Ulrike Bauder‐Wüst, Uwe Haberkorn, Michael Eisenhut, Klaus Kopka

Activation of the Cannabinoid Receptor Type 1 Decreases Glutamatergic and GABAergic Synaptic Transmission in the Lateral Amygdala of the Mouse mā Shahnaz Christina Azad, Matthias Eder, Giovanni Marsicano, Beat Lutz, W. Zieglgänsberger, Gerhard Rammes

PSMA-Targeting Radiopharmaceuticals for Prostate Cancer Therapy: Recent Developments and Future Perspectives mā Mohamed El Fakiri, Nicolas M. Geis, Nawal Ayada, Matthias Eder, Ann-Christin Eder

Enhanced sensitivity to inhibition of SHP2, STAT5, and Gab2 expression in chronic myeloid leukemia (CML) mā Michaela Scherr, Anuhar Chaturvedi, Karin Battmer, Iris Dallmann, Beate Schultheis, Arnold Ganser, Matthias Eder

Shc phosphorylation in myeloid cells is regulated by granulocyte macrophage colony-stimulating factor, interleukin-3, and steel factor and is constitutively increased by p210BCR/AB... mā Tetsuya Matsuguchi, Ravi Salgia, Michael Hallek, Matthias Eder, Brian J. Druker, T J Ernst, James D. Griffin

Incidence, risk factors and healthcare costs of central line-associated nosocomial bloodstream infections in hematologic and oncologic patients mā Claas Baier, Lena Linke, Matthias Eder, Frank Schwab, Iris F. Chaberny, Ralf‐Peter Vonberg, Ella Ebadi

Towards Improving the Efficacy of PSMA-Targeting Radionuclide Therapy for Late-Stage Prostate Cancer—Combination Strategies mā D. Arbuznikova, Matthias Eder, Anca‐Ligia Grosu, Philipp T. Meyer, Christian Gratzke, Constantinos Zamboglou, Ann-Christin Eder

A dimerized urea-based inhibitor of the prostate-specific membrane antigen for 68Ga-PET imaging of prostate cancer mā Martin Schäfer, Ulrike Bauder‐Wüst, Karin Leotta, Frederic Zoller, Walter Mier, Uwe Haberkorn, Michael Eisenhut, Matthias Eder

Lentivirus-mediated antagomir expression for specific inhibition of miRNA function mā Michaela Scherr, Letizia Venturini, Karin Battmer, Michael Schaller-Schoenitz, Daniel Schaefer, Iris Dallmann, Arnold Ganser, Matthias Eder

68Ga-PSMA-11 Dynamic PET/CT Imaging in Primary Prostate Cancer mā Christos Sachpekidis, Klaus Kopka, Matthias Eder, Boris Hadaschik, Martin T. Freitag, Leyun Pan, Uwe Haberkorn, Antonia Dimitrakopoulou‐Strauss

Ngā utauta rapu:

Ngā marau whai pānga